Open Access
Vet. Res.
Volume 41, Number 1, January-February 2010
Number of page(s) 14
Published online 03 September 2009
How to cite this article Vet. Res. (2010) 41:02
References of  Vet. Res. (2010) 41:02
  1. Alonso C., Oviedo J.M., Martín-Alonso J.M., Díaz E., Boga J.A., Parra F., Programmed cell death in the pathogenesis of rabbit hemorrhagic disease, Arch. Virol. (1998) 143:321–332 [CrossRef] [PubMed].
  2. Arbadi S., Maier R.V., Mitogen-activated protein kinases, Crit. Care Med. (2002) 30:S74–S78 [CrossRef].
  3. Bélanger M., Butterworth R.F., Acute liver failure: a critical appraisal of available animal models, Metab. Brain Dis. (2005) 20:409–423 [CrossRef] [PubMed].
  4. Chen L.W., Chang W.J., Wang J.S., Hsu C.M., Thermal injury-induced peroxynitrite production and pulmonary inducible nitric oxide synthase expression depend on JNK/AP-1 signaling, Crit. Care Med. (2006) 34:142–150 [CrossRef] [PubMed].
  5. Chen W.Y., Ho K.C., Leu J.H., Liu K.F., Wang H.C., Kou G.H., Lo C.F., WSSV infection activates STAT in shrimp, Dev. Comp. Immunol. (2008) 32:1142–1150 [CrossRef] [PubMed].
  6. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., González-Gallego J., Quercetin decreases oxidative stress, NF-kappaB activation and iNOS overexpression in liver of streptozotocin induced diabetic rats, J. Nutr. (2005) 135:2299–2304 [PubMed].
  7. Duechting A., Tschöpe C., Kaiser H., Lamkemeyer T., Tanaka N., Aberle S., et al., Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells, J. Virol. (2008) 82:7942–7952 [CrossRef] [PubMed].
  8. Ekstrand-Hammarström B., Osterlund C., Lilliehöök B., Bucht A., Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells, Clin. Exp. Immunol. (2007) 147:359–369 [PubMed].
  9. Galun E., Zeira E., Pappo O., Peters M., Rose-John S., Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury, FASEB J. (2000) 14:1979–1987 [CrossRef] [PubMed].
  10. Gao B., Cytokines, STATs and liver disease, Cell. Mol. Immunol. (2005) 2:92–100 [PubMed].
  11. García-Mediavilla M.V., Crespo I., Collado P.S., Esteller A., Sánchez-Campos S., Tuñón M.J., González-Gallego J., Anti-inflammatory effect of the flavones quercetin and kaempferol in Chang Liver cells involves inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway, Eur. J. Pharmacol. (2007) 557:221–229 [CrossRef] [PubMed].
  12. Han C., Li G., Lim K., Defrances M.C., Gandhi C.R., Wu T., Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure, J. Immunol. (2008) 181:8027–8035 [PubMed].
  13. Ip Y.T., Davis R.J., Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development, Curr. Opin. Cell Biol. (1998) 10:205–219 [CrossRef] [PubMed].
  14. Katsuma S., Mita K., Simada T., ERK- and JNKdependent signaling pathways contribute to Bombyx mori nucleopolyhedrovirus infection, J. Virol. (2007) 81:13700–13709 [CrossRef] [PubMed].
  15. Kim W.H., Hong F., Radaeva S., Jaruga B., Fan S., Gao B., STAT1 plays an essential role in LPS/Dgalactosamine-induced liver apoptosis and injury, Am. J. Physiol. Gastrointest. Liver Physiol. (2003) 285:761–768.
  16. Kolch W., Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions, Biochem. J. (2000) 351:289–305 [CrossRef] [PubMed].
  17. Kretzmann N.A., Fillmann H., Mauriz J.L., Marroni C.A., Marroni N., González-Gallego J., Tuñón M.J., Effects of glutamine on pro-inflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in experimental colitis, Inflamm. Bowel Dis. (2008) 14:1504–1513 [CrossRef] [PubMed].
  18. Lee W.M., Acute liver failure in the United States, Semin. Liver Dis. (2003) 23:217–226 [CrossRef] [PubMed].
  19. Liu S.J., Xue H.P., Pu B.Q., Quia N.H., A new viral disease in rabbits, Anim. Husb. Vet. Med. (1984) 16:253–255.
  20. Maeda S., Chang L., Li Z.W., Luo J.L., Leffert H., Karin M., IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha, Immunity (2003) 19:725–737 [CrossRef] [PubMed].
  21. Martínez-Flores S., Gutiérrez-Fernández B., Sánchez-Campos S., Gonzalez-Gallego J., Tuñón M.J., Quercetin prevents nitric oxide production and nuclear factor kappa B activation in interleukin-1bactivated rat hepatocytes, J. Nutr. (2005) 135:1359–1365 [PubMed].
  22. Mauriz J.L., Matilla B., Culebras J.M., González P., González-Gallego J., Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat, Free Radic. Biol. Med. (2001) 31:1236–1244 [CrossRef] [PubMed].
  23. Meraz M.A., White J.M., Sheehan K.C., Bach C.A., Rodig S.J., Dighe A.S., et al., Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway, Cell (1996) 84:431–442 [CrossRef] [PubMed].
  24. Mikami O., Hepatic lesions in young rabbits experimentally infected with rabbit haemorrhagic disease virus, Res. Vet. Sci. (1999) 66:237–242 [CrossRef] [PubMed].
  25. Moreira A., Fraga C., Alonso M., Collado P.S., Zettler C., Marroni C., et al., Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats, Biochem. Pharmacol. (2004) 68:1939–1946 [CrossRef] [PubMed].
  26. Muto Y., Nouir-Aria K.T., Meager A., Alexander G.J., Edlleston A.L., Williams R., Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure, Lancet (1988) 2:72–74 [CrossRef] [PubMed].
  27. Nakama T., Hirono S., Moriuchi A., Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality, Hepatology (2001) 33:1441–1450 [CrossRef] [PubMed].
  28. Pan H., Xie J., Ye F., Gao S.J., Modulation of Kaposis's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple-mitogen-activated protein kinase pathways during primary infection, J. Virol. (2006) 80:5371–5382 [CrossRef] [PubMed].
  29. Panteva M., Korkaya H., Jameel S., Hepatitis viruses and the MAPK pathway: is this a survival strategy?, Virus Res. (2003) 92:131–140 [CrossRef] [PubMed].
  30. Pauli E.K., Schmolke M., Wolff T., Viemann D., Roth J., Bode J.G., Ludwig S., Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression, PLoS Pathog. (2008) 4:e1000196.
  31. Persico T., Savasi V., Ferrazzi E., Oneta M., Semprini A.E., Simoni G., Detection of human immunodeficiency virus-1 RNA and DNA by extractive and in situ PCR in unprocessed semen and seminal fractions isolated by semen-washing procedure, Hum. Reprod. (2006) 2:1525–1530 [CrossRef].
  32. Pestka S., The human interferon alpha species and receptors, Biopolymers (2000) 55:254–287 [CrossRef] [PubMed].
  33. Qiu Z., Kwon A.H., Tsuji K., Kamiyama Y., Okumura T., Hirao Y., Fibronectin prevents D-galactosamine/lipopolysaccharide-induced lethal hepatic failure in mice, Shock (2006) 25:80–87 [CrossRef] [PubMed].
  34. Rutherford A., Chung R.T., Acute liver failure: mechanisms of hepatocyte injury and regeneration, Semin. Liver Dis. (2008) 28:167–174 [CrossRef] [PubMed].
  35. Sánchez-Campos S., A' lvarez M., Culebras J.M., González-Gallego J., Tuñón M.J., Pathogenic molecular mechanisms in an animal model of fulminant hepatic failure: rabbit hemorrhagic viral disease, J. Lab. Clin. Med. (2004) 144:215–222 [CrossRef] [PubMed].
  36. San-Miguel B., A' lvarez M., Culebras J.M., González-Gallego J., Tuñón M.J., N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure, Apoptosis (2006) 11:1945–1957 [CrossRef] [PubMed].
  37. Schattenberg J.M., Singh R., Wang Y., Lefkowitch J.H., Rigoli R.M., Scherer P.E., et al., JNK1 but not JNK2 promotes the development of steatohepatitis in mice, Hepatology (2006) 43:163–172 [CrossRef] [PubMed].
  38. Schwabe R.F., Bradham C.A., Uehara T., Hatano E., Bennett B.L., Schoonhoven R., Brenner D.A., c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration, Hepatology (2003) 37:824–832 [CrossRef] [PubMed].
  39. Stravitz R.T., Critical management decisions in patients with acute liver failure, Chest (2008) 134:1092–1102 [CrossRef] [PubMed].
  40. Streetz K., Leifeld L., Grundmann D., Ramakers J., Eckert J., Spengler U., et al., Tumor necrosis factor a in the pathogenesis of human and murine fulminant hepatic failure, Gastroenterology (2000) 119:446–460 [CrossRef] [PubMed].
  41. Suzuki Y.J., Forman H.J., Sevanian A., Oxidants as stimulators of signal transduction, Free Radic. Biol. Med. (1997) 22:269–285 [CrossRef] [PubMed].
  42. Takahashi K., Umehara Y., Umehara M., Nishimura A., Naruumi S., Toyoki Y., et al., Plasma exchange-based plasma recycling dialysis system as an artificial liver support, Ther. Apher. Dial. (2008) 12:264–270 [CrossRef] [PubMed].
  43. Takamura M., Matsuda Y., Yamagiwa S., Tamura Y., Honda Y., Suzuki S., et al., An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharideinduced hepatic failure by modulating BH3-only proteins, Life Sci. (2007) 80:1335–1344 [CrossRef] [PubMed].
  44. Taub R., Hepatoprotection via the IL-6/Stat3 pathway, J. Clin. Invest. (2003) 112:978–980 [PubMed].
  45. Tung W.H., Sujn C.C., Hsieh H.L., Wang S.W., Horng J.T., Yang C.M., EV71 induces VCAM-1 expression via PDGF receptor, PI3-K/Akt, p38 MAPK, JNK and NF-kappa B in vascular smooth muscle cells, Cell. Signal. (2007) 19:2127–2137 [CrossRef] [PubMed].
  46. Tuñón M.J., Sa'nchez-Campos S., García-Ferreras J., Alvarez M., Jorquera F., Gonzalez-Gallego J., Rabbit hemorrhagic viral disease: characterization of a new animal model of fulminant liver failure, J. Lab. Clin. Med. (2003) 141:272–278 [CrossRef] [PubMed].
  47. Tuñón M.J., Alvarez M., Culebras J.M., González-Gallego J., An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure, World J. Gastroenterol. (2009) 15:3086–3098 [CrossRef] [PubMed].
  48. Van de Kerkhove M.P., Hoekstra R., Chamuleau R.A., van Gulik T.M., Clinical application of bioarti-ficial liver support systems, Ann. Surg. (2004) 240:216–230 [CrossRef] [PubMed].
  49. Whitmarsh A.J., Davis R.J., Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways, J. Mol. Med. (1996) 74:589–607 [CrossRef] [PubMed].
  50. Vlotides G., Sörensen A.S., Kopp F., Zitzmann K., Cengic N., Brand S., et al., SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA, Biochem. Biophys. Res. Commun. (2004) 320:1007–1014 [CrossRef] [PubMed].
  51. Wolf D., Hallmann R., Sass G., Sixt M., Kusters S., Fregien B., et al., TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis, J. Immunol. (2001) 166:1300–1307 [PubMed].
  52. Yamada Y., Kirillova I., Peschon J.J., Fausto N., Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor, Proc. Natl. Acad. Sci. USA (1997) 94:1441–1446 [CrossRef] [PubMed].
  53. Yeh C., Lin P.Y., Liao M.H., Liu H.J., Lee J.W., Chiu S.J., et al., TNF-$\alpha$ mediates pseudorabies virus-induced apoptosis via activation of p38 MAPK and JNK/SAPK signaling, Virology (2008) 381:55–66 [CrossRef] [PubMed].
  54. Zhu H., Shang X., Terada N., Liu C., STAT3 induces anti-hepatitis C viral activity in liver cells, Biochem. Biophys. Res. Commun. (2004) 324:518–528 [CrossRef] [PubMed].